Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.21.35 extracted from

  • Chao, J.; Yin, H.; Gao, L.; Hagiwara, M.; Shen, B.; Yang, Z.R.; Chao, L.
    Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation (2008), Hypertension, 52, 715-720.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine kallikrein improves cardiac function and reduces infarct size in kininogen-deficient rats, icatibant and N-alpha-nitro-L-arginine-methyl-ester block kallikrein's cardioprotective effects Rattus norvegicus

Inhibitors

Inhibitors Comment Organism Structure
Aprotinin tissue kallikrein is inactivated by incubation with 5fold molar excess of aprotinin at 37°C for 1 h Rattus norvegicus

Organism

Organism UniProt Comment Textmining
Rattus norvegicus
-
-
-

Purification (Commentary)

Purification (Comment) Organism
-
Rattus norvegicus

Source Tissue

Source Tissue Comment Organism Textmining
cardiomyocyte
-
Rattus norvegicus
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
D-Val-Leu-Arg-4-nitroanilide + H2O also known as S2266, a chromogenic substrate for tissue kallikrein Rattus norvegicus D-Val-Leu-Arg + 4-nitroaniline
-
?
kinin B2 receptor + H2O tissue kallikrein directly activates kinin B2 receptor in the absence of kininogen Rattus norvegicus ?
-
?